Subspecialties

Why AS-imaging is my gold standard method for diagnosing and monitoring angle-closure glaucoma.

Is pegpleranib + ranibizumab better than ranibizumab alone? Phase III results suggest not…

Gene associated with early onset Parkinson’s disease appears to act against cataract formation.

Real-world observational study comparing ranibizumab and aflibercept shows similar outcomes.

Looking back at 2016's predictions of the future.

When it comes to treating retinal disease, VEGF isn’t the only game in town.

We Sit Down With George O. Waring IV, Director of Refractive Surgery, MUSC.

Heidelberg Engineering has started delivering the OCT-Angiography Module to SPECTRALIS® customers outside the United States. The OCT Angiography Module non-invasively produces detailed three-dimensional representations of the perfused retinal and choroidal vasculatures.

Francesco Carones explains how the AcrySof IQ PanOptix IOL has affected his patient selection.

Dr. Gerhard Zinser, co-founder and Managing Director of Heidelberg Engineering, is the first non-clinician to be honored with this prestigious award. Earlier this year he was also elected as part of The Ophthalmologist’s Power List of the top 100 most influential people in ophthalmology.